Detalhe da pesquisa
1.
Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis.
Kidney Int
; 100(6): 1316-1324, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34560140
2.
Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis.
Kidney Int
; 95(3): 655-665, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655025
3.
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis.
Rheumatology (Oxford)
; 58(2): 260-268, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30239910
4.
Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis.
Nephrol Dial Transplant
; 34(1): 63-73, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29462348
5.
Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial.
BMC Nephrol
; 20(1): 352, 2019 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31492152
6.
Ofatumumab for B cell depletion in patients with systemic lupus erythematosus who are allergic to rituximab.
Rheumatology (Oxford)
; 57(7): 1156-1161, 2018 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29562252
7.
Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients-a potential biomarker of disease activity.
Rheumatology (Oxford)
; 56(7): 1206-1216, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28387859
8.
Ofatumumab for B cell depletion therapy in ANCA-associated vasculitis: a single-centre case series.
Rheumatology (Oxford)
; 55(8): 1437-42, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27094598
9.
Glucocorticoid-free treatment of severe ANCA-associated vasculitis.
Nephrol Dial Transplant
; 36(4): 739-742, 2021 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367854
10.
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis.
Rheumatology (Oxford)
; 58(2): 373, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30690635
11.
Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis.
Nephrol Dial Transplant
; 33(5): 899, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29617842
12.
Immune gene expression and functional networks in distinct lupus nephritis classes.
Lupus Sci Med
; 9(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074933
13.
Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus.
Nat Commun
; 12(1): 1980, 2021 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33790300
14.
Eculizumab as rescue therapy in severe resistant lupus nephritis.
Rheumatology (Oxford)
; 54(12): 2286-8, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26316577
15.
Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial.
Clin J Am Soc Nephrol
; 15(2): 209-218, 2020 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31953303
16.
Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
Nephrol Dial Transplant
; 19(12): 3062-7, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15507477
17.
Tesio-Caths provide effective and safe long-term vascular access.
Nephrol Dial Transplant
; 19(11): 2816-22, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15340094